
A boy shouldn’t be eligible for specialist drug therapy as a result of his uncommon and incurable tumour is a millimetre too small, his dad and mom have stated.
Ronnie Hood, 11, from Sudbury, Suffolk, was identified with a diffuse midline glioma in March after medical doctors have been unable to take away the whole thing of a tumour rising on his backbone and mind.
After being given simply 9 months to reside, the teenager went by chemotherapy and radiotherapy periods which helped shrink the tumour, however solely barely.
The discount, nevertheless, was sufficient to imply he wouldn’t qualify for ONC201 – an experimental drug used to deal with critical mind tumours in younger adults.

“We obtained the information it had shrunk, which is clearly excellent information, however the double-edged sword was that we at the moment are not eligible for the drug,” stated his dad Nick.
“If there’s a change then we might be eligible however within the meantime we’re sourcing it ourselves, but it surely prices about £700 per capsule or it might be about £4,000 a month.”
Mr Hood, 58, and Ronnie’s mom Vicky, 50, took their son to be checked out in February 2023 after he stated his neck was hurting and he had a tingling feeling in his fingers.
It was initially suspected the ache could also be a results of his gaming, so he was despatched for physiotherapy earlier than ultimately being despatched for an pressing MRI roughly a yr later.

Talking concerning the second she was instructed of her son’s prognosis, after an eight-hour operation at Addenbrooke’s Hospital, Mrs Hood stated: “I broke down and could not consider what was occurring.
“I felt responsible as a result of it took practically a yr for him to be identified but it surely’s very aggressive and really, very uncommon, so even when we’d caught it earlier it would not have made a distinction.
“He is just one of a handful of individuals in the entire world who have gotten this mutation on their backbone – it is simply horrific.
“Ronnie has gone from bouncing off the partitions, driving his bike, doing artwork and taking place the park together with his buddies to not having the ability to use his fingers.
“I’ve to decorate him, feed him and bathe him. He can do hardly something now and so it’s horrific to look at him.”

While ONC201 shouldn’t be obtainable on the NHS, treating physicians can request it from Chimerix, an organization which is working an expanded (managed) entry programme for the drug.
Ronnie’s prolonged relations have arrange a fundraising marketing campaign in an effort to lift £50,000 to assist fund the acquisition of ONC201 and different therapies privately.
So far practically £30,000 has been donated.
“We cannot thank everybody sufficient. Everyone has been superb,” Mrs Hood stated.
“Ronnie has additionally been completely superb. He is so sturdy to deal with what he is needed to undergo and he nonetheless giggles and performs on-line together with his buddies.
“He is simply an incredible little boy, he actually is.”
Bosses on the Cambridge University Hospitals NHS Foundation Trust, which runs Addenbrooke’s Hospital, stated they have been “devoted to offering the easiest ranges of care”.
A spokesperson stated: “While we have now each sympathy for Ronnie and his household, and have approached the pharmaceutical firm on their behalf, you will need to perceive this drug is simply obtainable by a managed entry programme instantly from the pharmaceutical firm by assembly their eligibility standards.”
Chimerix has been contacted for remark.